Nurix Therapeutics Insider Moves and Insights for Investors
A Nurix Therapeutics insider recently sold shares, drawing attention from investors. This article breaks down the mov...
At age 50, you can make catch-up contributions to enhance your retirement savings. Understand how to take full advantage of this opportunity.
9,239 articlesA Nurix Therapeutics insider recently sold shares, drawing attention from investors. This article breaks down the mov...
Celanese (CE) stands at an inflection point as 2026 begins. This article breaks down the potential drivers behind cel...
Gas costs in Indiana have climbed, lifting the state into the higher end of the price spectrum. This article explains...
When a legendary brand names a new leader, investors lean in. Disney's CEO, Josh D'Amaro, arrives with a plan to shar...
Tesla is recalling more than 218,000 cars and SUVs due to a rearview camera delay that could impair reversing visibil...
This guide breaks down what Greenlight Re (GLRE) investors should watch in the first-quarter 2026 results. Learn how ...
Horizon (HRZN) investors want clarity on Q3 2025 results and what comes next. This article breaks down horizon (hrzn)...
Sportradar is at a pivotal moment as 2026 earnings unfold. This guide breaks down the numbers, the drivers behind gro...
Realty Income kicks off 2026 with steady cash flow and high occupancy. This guide breaks down the Q1 results, what th...
MIAX is shaping 2026 in a dynamic way, and the first-quarter earnings transcript offers clues about growth drivers an...
AI stocks soared for years, then faced a rigorous test as valuations and demand shifted. This article breaks down wha...
Do well carbon taxes match the promises policymakers make? This deep dive examines 2023 evidence, compares design cho...